clinical trial · NCT07272889
Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG)
Healthy Volunteer StudyEthinyl Estradioll/Levonorgestrel (EE/LNG)Bemnifosbuvir/Ruzasvir (BEM/RZR)Bemnifosbuvir/Ruzasvir (BEM/RZR) + Ethinyl Estradioll/Levonorgestrel (EE/LNG)
brief summary
Drug-drug interaction study between Ethinyl Estradioll/Levonorgestrel and Bemnifosbuvir/Ruzasvir
started
Dec 4, 2025
primary completion
Feb 17, 2026
completion
Feb 17, 2026
last updated
Apr 13, 2026
official title
A Phase 1, Open-Label Study to Evaluate the Effect of Multiple Oral Doses of Bemnifosbuvir/Ruzasvir Fixed-dose Combination on the Single-Dose Pharmacokinetics of a Combined Oral Contraceptive (Ethinyl Estradiol/ Levonorgestrel) in Healthy Adult Female Participants of Non-Childbearing Potential
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol